Sign in

RTI Health Solutions

@rti-hs.bsky.social
86 followers 102 following 42 posts

We partner with pharmaceutical and medical device developers to provide critical strategy and integrated evidence generation throughout product development lifecycles. www.rtihs.org

PostsRepliesMedia
RTI Health Solutions @rti-hs.bsky.social · 08/12/2025
ISPOR Europe 2025 highlighted that patient voice drives #HTA, value, and access. PROs, COAs, preference evidence, real-world data, and #JCA all matter — integrate early for stronger, decision-ready submissions. Read more: ow.ly/9XnQ50XFTuS
ISPOR EU 2025 Recap Blog
020
RTI Health Solutions @rti-hs.bsky.social · 20/11/2025
ow.ly/y4I550XuUw1 EU Joint Clinical Assessments are reshaping orphan drug access in Europe. Download RTI Health Solutions’ free report for the key challenges, evidence needs, and strategies to stay ahead. #OrphanDrugs #RareDisease #JCA
Blueprint graphic with the number 1 and text: “Plan Early, Plan Smart.”Blueprint graphic with the number 2 and text: “Build on Solid Strategy.”Blueprint graphic with the number 3 and text: “Validate and Align Early.”Blueprint graphic with the number 4 and text: “Be Ready—From Dossier to Decision,” plus a small image of the JCA report.
010
RTI Health Solutions @rti-hs.bsky.social · 07/11/2025
We're excited to announce that we've expanded our collaboration with Bekhealth and Innovo Research to set a new standard for how EHR data is transformed into actionable intelligence for clinical research and RWE. -> ow.ly/kqFm50Xo1mB #drugdevelopment #HealthOutcomes 🧪 PharmSky Medsky
RTI Health SOlutions expand partnership with Bekhealth and Innovo Research.
020
RTI Health Solutions @rti-hs.bsky.social · 25/09/2025
What happens when you need clear, expert-driven guidance on when and how a therapy should be used in clinical practice? We used a Delphi panel approach—bringing together expert consensus to inform treatment guidelines. See the case study -> ow.ly/e09o50WxrFb 🧪 PharmSky Medsky #medaffairs
010
RTI Health Solutions @rti-hs.bsky.social · 18/09/2025
ow.ly/AksJ50WYfNS 🚀 Pharma innovation doesn’t end at approval—it begins with adoption. Why do some breakthrough therapies struggle to gain traction in the real world? Our latest whitepaper explores how Implementation Science can bridge the gap. 🧪 PharmSky Medsky
Drawing showing construction of a building with the title Leveraging Implementation Science for Sustainable Innovation.
010
RTI Health Solutions @rti-hs.bsky.social · 16/09/2025
Smarter pharma research starts with responsible AI. RTI Health Solutions is leading the way with: ✅ Validated Artificial Intelligence tools ✅ Human oversight ✅ Global compliance Let’s innovate with integrity.🔗Learn more about our approach at ow.ly/sN4550WXs2c #PharmaInnovation 🧪 PharmSky Medsky
hand pointing at shield with check mark on it. Text: Responsible AI in Health Science, RTI Health Solutions
010
RTI Health Solutions @rti-hs.bsky.social · 11/09/2025
Developing an ultra-rare disease therapy? Identifying a suitable comparator for pricing and reimbursement can be a big hurdle. Here's how we helped a client navigate complex global market access challenges with a strategic roadmap for regional value dossiers. ow.ly/NsNB50WxspH 🧪 PharmSky Medsky
010
RTI Health Solutions @rti-hs.bsky.social · 04/09/2025
What a week at #ISPEAnnual2025 in DC! From powerful sessions to meaningful connections, we left inspired. 💡 Check out the research we presented and follow-up with our team at ow.ly/V8Ee50WRx0R
011
RTI Health Solutions @rti-hs.bsky.social · 04/09/2025
Are you leveraging Implementation Science in your Pharma or MedTech research? This proactive, evidence-based model helps anticipate and overcome barriers to adoption—accelerating the integration of innovative therapies into clinical practice. Download the whitepaper at go.rti.org/LeverageImpSci
000
RTI Health Solutions @rti-hs.bsky.social · 03/09/2025
The TARGET Guideline for target trial emulation is now publicly available. This new guideline will improve reporting transparency of studies using real-world data to emulate a pragmatic randomized trial and improve clarity, completeness, and credibility of findings. Learn more at ow.ly/vLpa50WPPHr
Logo for the TARGET Guideline with article title, RTI-HS branding on a blue background
010
RTI Health Solutions @rti-hs.bsky.social · 21/08/2025
🧬 A biopharmaceutical company needed to validate its health economic model for a rare disease across healthcare systems. See how RTI Health Solutions helped them navigate regional complexities and ensure their model stood up to scrutiny. ow.ly/t9ek50WxrwX Pharma Strategy, Value Assessment
Image of child in hospital bead with banner RTI hs Case Study and title of case study.
000
RTI Health Solutions @rti-hs.bsky.social · 19/03/2025
The recording is here! If you missed our webinar on unlocking the full potential of literature reviews in your pharmaceutical or health technology asset development, you can watch it here-> ow.ly/i9Cn50V63Lm #pharmaceutical #healthtechnology #litreviews
000
RTI Health Solutions @rti-hs.bsky.social · 19/02/2025
If you are working on health research studies with UK data, who is accessing, managing, and interpreting that data for you? Our researchers can determine whether CPRD data may be the best option for your research questions. ow.ly/fpc750UR4oT #realworldevidence #realworlddata 🧪PharmSky
Text: Maximize your data for health outcomes, regulatory, and safety research. On blue background with RTI-HS logo.
011